1. Home
  2. ATOS vs UNB Comparison

ATOS vs UNB Comparison

Compare ATOS & UNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • UNB
  • Stock Information
  • Founded
  • ATOS 2009
  • UNB 1891
  • Country
  • ATOS United States
  • UNB United States
  • Employees
  • ATOS N/A
  • UNB N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • UNB Major Banks
  • Sector
  • ATOS Health Care
  • UNB Finance
  • Exchange
  • ATOS Nasdaq
  • UNB Nasdaq
  • Market Cap
  • ATOS 107.2M
  • UNB 119.3M
  • IPO Year
  • ATOS 2012
  • UNB 1998
  • Fundamental
  • Price
  • ATOS $0.78
  • UNB $27.20
  • Analyst Decision
  • ATOS Strong Buy
  • UNB
  • Analyst Count
  • ATOS 3
  • UNB 0
  • Target Price
  • ATOS $6.17
  • UNB N/A
  • AVG Volume (30 Days)
  • ATOS 1.3M
  • UNB 6.8K
  • Earning Date
  • ATOS 08-12-2025
  • UNB 10-15-2025
  • Dividend Yield
  • ATOS N/A
  • UNB 5.55%
  • EPS Growth
  • ATOS N/A
  • UNB N/A
  • EPS
  • ATOS N/A
  • UNB 2.01
  • Revenue
  • ATOS N/A
  • UNB $48,950,000.00
  • Revenue This Year
  • ATOS N/A
  • UNB N/A
  • Revenue Next Year
  • ATOS N/A
  • UNB N/A
  • P/E Ratio
  • ATOS N/A
  • UNB $12.90
  • Revenue Growth
  • ATOS N/A
  • UNB 2.99
  • 52 Week Low
  • ATOS $0.55
  • UNB $24.11
  • 52 Week High
  • ATOS $1.66
  • UNB $37.70
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 45.59
  • UNB 51.09
  • Support Level
  • ATOS $0.81
  • UNB $25.94
  • Resistance Level
  • ATOS $0.80
  • UNB $27.65
  • Average True Range (ATR)
  • ATOS 0.03
  • UNB 0.79
  • MACD
  • ATOS -0.00
  • UNB 0.04
  • Stochastic Oscillator
  • ATOS 39.58
  • UNB 70.65

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

Share on Social Networks: